Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
76 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)
The global market for stem cells is expected to reach USD 170.15 billion by 2020. Growing prevalence of chronic diseases such as cardiovascular and liver disease, diabetes and cancer coupled with the presence of high unmet medical needs in these disease segments is expected to drive market growth during the forecast period. Moreover, increasing government support pertaining to funding R&D initiatives and the growing demand for medical tourism and stem cell banking services is expected to boost the demand for stem cells over the next six years. The future of this market is expected to be driven by opportunities such as the growing global prevalence of neurodegenerative diseases, increasing demand for contract research outsourcing services and the substitution of animal tissues by stem cells.
The stem cells technology market was valued at USD 12.88 billion in 2013 and is expected to grow at a CAGR of over 12.0% during the forecast period. This market was dominated by the cell acquisitions technology segment in terms of share in 2013 owing to the fact that this technology serves as the foremost step to process involving stem cells culture. The global stem cell acquisition technology market is expected to reach USD 10.88 billion by 2020, growing at a CAGR of over 14.0% over the next six years.
Further key findings from the study suggest:
Adult stem cells segment dominated the overall market in 2013 with a share of over 80.0% on account of features such as low contamination probability, better acceptance by the human body and a relatively easier harvesting procedure
Regenerative medicine was identified as the largest stem cells application market and was valued at USD 30.16 billion in 2013. High global prevalence of neurology and orthopedic disorders and cancer is one of the most significant drivers of this market.
North America was the largest regional market in 2013, accounting for over 55% of global revenue. The presence of sophisticated healthcare infrastructure supporting R&D and strong government support in terms of funding are some of the drivers attributing to its large share.
Asia Pacific is expected to grow at the highest CAGR of over 25.0% during the forecast period owing to the growing demand for medical tourism and contract research outsourcing in emerging countries such as China and India
Key industry participants include BioTime Inc., Advanced Cell Technology Inc., Cellular Engineering Technologies Inc., STEMCELL Technologies Inc., and Cellartis AB
For the purpose of this study, Grand View Research has segmented the global stem cells market on the basis of product, application, technology and region:
Stem Cells Product Outlook
Stem Cells Platforms
Sequence Analysis Platforms
Adult Stem Cells
Hematopoietic Stem Cells
Mesenchymal Stem Cells
Neuronal Stem Cells
Dental Stem Cells
Umbilical Cord Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Natural Rosette Cells
Very Small Embryonic Like Stem Cells
Stem Cells Application Outlook
Regenerative Medicine
Neurology
Orthopedics
Oncology
Hematology
Cardiovascular and Myocardial Infraction
Injuries
Diabetes
Liver Disorder
Incontinence
Others (Crohn's Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
Drug Discovery and Development
Stem Cells Technology Outlook
Cell Acquisition
Bone Marrow Harvest
Apheresis
Umbilical Blood Cord
Cell Production
Therapeutic Cloning
In Vitro Fertilization
Isolation
Cell Culture
Cryopreservation
Expansion and Sub-Culture
Stem Cells Regional Outlook
North America
Europe
Asia Pacific
RoW
Table of Contents
Chapter 1. Executive Summary 1.1. Stem Cells - Industry Summary and Critical Success Factors (CSFs) Chapter 2. Stem Cells Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Stem Cells Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Stem Cells Market PESTEL Analysis, 2012 Chapter 3. Stem Cells Product Outlook 3.1.1. Adult Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.1.1. Hematopoietic Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.1.2. Mesenchymal Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.1.3. Neuronal Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.1.4. Dental Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.1.5. Umbilical Cord Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.2. Human Embryonic Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.3. Induced Pluripotent Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.4. Natural Rosette Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.5. Very Small Embryonic Like Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) Chapter 4. Stem Cells Application Outlook 4.1.1. Regenerative Medicine Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.1. Neurology Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.2. Orthopedics Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.3. Oncology Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.4. Hematology Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.5. Cardiovascular and Myocardial Infraction Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.6. Injuries Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.7. Diabetes Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.8. Liver Disorder Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.9. Incontinence Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.10. Others Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.2. Drug Discovery and Development Market Estimates and Forecasts, 2012 - 2020 (USD Million) Chapter 5. Stem Cells Technology Outlook 5.1. Cell Acquisition Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.1.1. Bone Marrow Harvest Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.1.2. Apheresis Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.1.3. Umbilical Blood Cord Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.2. Cell Production Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.2.1. Therapeutic Cloning Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.2.2. In Vitro Fertilization Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.2.3. Isolation Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.2.4. Cell Culture Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.3. Cryopreservation Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.4. Expansion and Sub-Culture Market Estimates and Forecasts, 2012 - 2020 (USD Million) Chapter 6. Stem Cells Regional Outlook 6.1. North America 6.1.1. Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 6.1.2. Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 6.1.3. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million) 6.2. Europe 6.2.1. Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 6.2.2. Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 6.2.3. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million) 6.3. Asia Pacific 6.3.1. Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 6.3.2. Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 6.3.3. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million) 6.4. RoW 6.4.1. Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 6.4.2. Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 6.4.3. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million) Chapter 7. Stem Cells Competitive landscape 7.1 Advanced Cell Technology Inc. 7.1.1 Company Overview 7.1.2 Financial Performance 7.1.3 Product Benchmarking 7.1.4 Strategic Initiatives 7.2 STEMCELL Technologies Inc. 7.2.1 Company Overview 7.2.2 Financial Performance 7.2.3 Product Benchmarking 7.2.4 Strategic Initiatives 7.3 Cellular Engineering Technologies Inc. 7.3.1 Company Overview 7.3.2 Financial Performance 7.3.3 Product Benchmarking 7.3.4 Strategic Initiatives 7.4 BioTime Inc. 7.4.1 Company Overview 7.4.2 Financial Performance 7.4.3 Product Benchmarking 7.4.4 Strategic Initiatives 7.5 Cellartis AB 7.5.1 Company Overview 7.5.2 Financial Performance 7.5.3 Product Benchmarking 7.5.4 Strategic Initiatives 7.6 Angel Biotechnology 7.6.1 Company Overview 7.6.2 Financial Performance 7.6.3 Product Benchmarking 7.6.4 Strategic Initiatives 7.7 Bioheart Inc. 7.7.1 Company Overview 7.7.2 Financial Performance 7.7.3 Product Benchmarking 7.7.4 Strategic Initiatives 7.8 BrainStorm Cell Therapeutics 7.8.1 Company Overview 7.8.2 Financial Performance 7.8.3 Product Benchmarking 7.8.4 Strategic Initiatives 7.9 Celgene Corporation 7.9.1 Company Overview 7.9.2 Financial Performance 7.9.3 Product Benchmarking 7.9.4 Strategic Initiatives 7.10 Osiris Therapeutics 7.10.1 Company Overview 7.10.2 Financial Performance 7.10.3 Product Benchmarking 7.10.4 Strategic Initiatives Chapter 8. Methodology and Scope 8.1. Research Methodology 8.2. Research Scope & Assumption 8.3. List of Data Sources List of Tables Stem Cells - Industry summary & Critical Success Factors (CSFs) Global Stem Cells revenue, 2012 - 2020 Global Stem Cells market revenue by region, (USD million), 2012 - 2020 Global Stem Cells market revenue by products, (USD million), 2012 - 2020 Global Stem Cells platforms, 2012 to 2020 (USD million) Global Stem Cells Market, by Region, 2012 to 2020 (USD million) Global Stem Cells Market, by Technology, 2012 - 2020 (USD million) Global Stem Cells Market, by Applications, 2012 - 2020 (USD million) North America Stem Cells demand, by products, (USD million), 2012 - 2020 North America Stem Cells demand, by applications, (USD million), 2012 - 2020 North America Stem Cells demand, by technology, (USD million), 2012 - 2020 Europe Stem Cells demand, by products, (USD million), 2012 - 2020 Europe Stem Cells demand, by applications, (USD million), 2012 - 2020 Europe Stem Cells demand, by technology, (USD million), 2012 - 2020 Asia Pacific Stem Cells demand, by products, (USD million), 2012 - 2020 Asia Pacific Stem Cells demand, by applications, (USD million), 2012 - 2020 Asia Pacific Stem Cells demand, by technology, (USD million), 2012 - 2020 RoW Stem Cells demand, by products, (USD million), 2012 - 2020 RoW Stem Cells demand, by applications, (USD million), 2012 - 2020 RoW Stem Cells demand, by technology, (USD million), 2012 - 2020 Global Stem Cells Market - Competitive Landscape List of Figures Stem Cells Market Segmentation Global Stem Cells Market Revenue, 2012 - 2020 Stem Cells Market Dynamics Key Opportunities Prioritized Industry Analysis - Porter's Stem Cells PESTEL Analysis, 2012 North America Stem Cells Market, 2012 - 2020 (USD Million) Europe Stem Cells Market, 2012 - 2020 (USD Million RoW Stem Cells Market, 2012 - 2020 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
